Human Disposition, Metabolism and Excretion of Etamicastat, a Reversible, Peripherally Selective Dopamine Β-Hydroxylase Inhibitor

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.12274
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

DOPAMINE Β-Hydroxylase INHIBITOR PRODUCED BY GLOEOPHYLLUM STRIATUM AND ITS IDENTITY WITH OOSPONOL

Journal of Antibiotics
Drug DiscoveryPharmacology
1972English

Low Serum Dopamine Β-Hydroxylase Activity

Journal of Clinical Investigation
Medicine
1978English

ENHANCEMENT OF DOPAMINE-INDUCED STIMULATION OF PANCREATIC SECRETION BY 5-Dimethyldithio-Carbamylpicolinic ACID (YP-279), a DOPAMINE Β-Hydroxylase INHIBITOR

The Japanese Journal of Pharmacology
1979English

Neurocognitive Function in Dopamine-Β-Hydroxylase Deficiency

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2011English

Dopamine-Β-Hydroxylase and Tyrosine Hydroxylase Activities in Brain Regions of Rolling Mouse Nagoya

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
1980English

FUSARIG ACID DERIVATIVES: THE EFFECT ON DOPAMINE Β-Hydroxylase

Journal of Antibiotics
Drug DiscoveryPharmacology
1973English

Electrochemistry of Dopamine Β-Hydroxylase in Adsorbed State at a Gold Electrode

Collection of Czechoslovak Chemical Communications
2004English

RFLP for Human DBH (Dopamine Beta-Hydroxylase)

Nucleic Acids Research
Genetics
1990English

Estimation of Human Serum Dopamine-^|^beta;-Hydroxylase Activity

Folia Endocrinologica Japonica
1973English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy